Serum GDH1/2 levels at the time of liver transplantation independently predicted the probability of tumor recurrence and microvascular invasion post-surgery, indicating a possible positive role of GDH1/2 in promoting HCC progression.247. This evidence concerns the gene GLUD1 and hepatocellular carcinoma.